Rare disease experts detail the first results of an unprecedented collaboration to diagnose people living with unsolved cases of rare diseases across Europe. The findings are published today in a series of six papers in the ...
Jun 1, 2021
0
2
The COLCORONA clinical study into using the inexpensive anti-inflammatory drug colchicine to treat COVID-19 was published today in the British journal The Lancet Respiratory Medicine, four months after the presentation of ...
May 28, 2021
0
2
While there was extensive use of drug repurposing throughout the first 10 months of the COVID-19 pandemic, there was substantial heterogeneity over the types of drugs used for treatment purposes globally. Some drugs, including ...
May 12, 2021
0
3
The pandemic has exposed troubling inequities in the United States that have left Black and Hispanic people at higher risk of dying from COVID-19—and getting a smaller share of vaccines.
Apr 16, 2021
0
1
New data published by researchers at The Ohio State University Comprehensive Cancer Center—Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC—James) suggests that an oral drug currently used ...
Apr 13, 2021
0
18
A new analysis of the entire genetic makeup of more than 53,000 people offers a bonanza of valuable insights into heart, lung, blood and sleep disorders, paving the way for new and better ways to treat and prevent some of ...
Apr 5, 2021
0
43
An international team of researchers examined the antibodies from a large cohort of COVID-19 patients. Due to the way antibodies are made, each person that is infected has the potential to produce many antibodies that target ...
Mar 25, 2021
0
55
Extremely preterm infants can suffer from a life-threatening inflammation of the gut. A new clinical study has shown that supplements of a lactic acid bacterium may have positive effects by increasing the diversity of intestinal ...
Mar 11, 2021
0
14
Several drugs already approved by the U.S. Food and Drug Administration (FDA) could potentially be used to alleviate the symptoms of COVID-19, biomedical researchers at Université de Montréal have found.
Dec 17, 2020
0
14
At the onset of the COVID-19 pandemic, just as public institutions and businesses closed, research programs performing human participant research (HPR) also largely ceased operations. Now, universities and healthcare organizations ...
Oct 5, 2020
0
0
